MLTX Insider Trading
Insider Ownership Percentage: 12.02%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $9,186,120.00
MoonLake Immunotherapeutics Insider Trading History Chart
This chart shows the insider buying and selling history at MoonLake Immunotherapeutics by year and by quarter.
Skip ChartChart Data in Insider Trading History Table
MoonLake Immunotherapeutics Share Price & Price History
Current Price: $38.05
Price Change: ▲ Price Increase of +1.7 (4.68%)
As of 04/2/2025 05:00 PM ET
MoonLake Immunotherapeutics Insider Trading History
SEC Filings (Institutional Ownership Changes) for MoonLake Immunotherapeutics (NASDAQ:MLTX)
93.85% of MoonLake Immunotherapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.
Institutional Buying and Selling by Quarter
This chart shows the instiutional buying and selling at MLTX by year and by quarter.
Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
MoonLake Immunotherapeutics Institutional Trading History
Data available starting January 2016
MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It develops Sonelokimab, a novel investigational Nanobody for the treatment of inflammation diseases; and hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, and psoriasis. MoonLake Immunotherapeutics was incorporated in 2020 and is headquartered in Zug, Switzerland.
Read More on MoonLake Immunotherapeutics
Today's Range
Now: $38.05
52 Week Range
Now: $38.05
Volume
680,471 shs
Average Volume
342,392 shs
Market Capitalization
$2.44 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.31
Who are the company insiders with the largest holdings of MoonLake Immunotherapeutics?